Summary
Profile
Financials
Events
Ownership
Options

Company Info

Industry Medical/Nursing Services
Sector Health Services
Employees 851
CEO Dr. Jianyu Yang
Address 18/F, Tower A, Global Trade Center 36 North Third Ring Road, Beijing, BE 100013
Phone 86.10.59036688
Website www.concordmedical.com

Concord Medical Services Holding Ltd. engages in the operation of radiotherapy and diagnostic imaging centers. It provides radiotherapy and diagnostic equipment leasing services to hospitals; and sale of medical equipment and the provision of radiotherapy and diagnostic equipment leasing and management services to hospitals, It operates through Network Business and Hospital Business segments. The company was founded on November 27, 2007 and is headquartered in Beijing, China.

Competitors

Company Name 3 Month
%Change
1 Year
%Change
Concord Medical Services Holding Ltd. 3.08% n/a
Triple-S Management Corp. 50.56% 78.62%
The Pennant Group, Inc. -28.39% -33.15%
Hanger, Inc. -23.17% 0.96%
ATI Physical Therapy, Inc. -53.27% -63.13%

Statement Summary

as of 4:10 ET PM 10/18/2021
Total Assets (MRQ) 513.8 M
Total Liabilities (MRQ) 303.9 M
Shareholders’ Equity (MRQ) 209.8 M
Total Revenue (Annual) 19.8 M
Net Income (Annual) -2.8 M

Earnings And Estimates

as of 4:10 ET PM 10/18/2021

Current Qtr EPS Estimate n/a
Current FY EPS Estimate n/a
Long Term EPS Growth Estimate 20.00
Next Expected Earnings Date //

CCM vs S&P 500

as of 10/18/2021
Relative To
S&P 500
CCM
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:10 ET PM 10/18/2021
Fiscal Quarter Estimate Actual Surprise
06/2019 -0.18 -0.17 -5.56%
03/2019 -0.03 -0.18 +500.00%
12/2018 0.08 0.08 0.00%
09/2018 0.07 0.07 0.00%
06/2018 0.15 0.14 -6.67%
03/2018 0.13 0.13 0.00%
12/2017 -0.47 -0.72 +53.19%
09/2017 -0.44 -0.44 0.00%

Financial Strength

as of 4:10 ET PM 10/18/2021
Pre-Tax Margin -5.93
Net Margin -167.09
Operating Margin -0.45
Return On Equity -12.15
Return On Assets -5.94
Inventory Turnover (TTM) 70.69
Sales Growth (MRQ) -19.92

Ratios

as of 4:10 PM ET 10/18/2021
Price/Earnings (TTM) n/a
Price/Book (MRQ) 0.00
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 0.00
Quick Ratio (MRQ) 0.97
Current Ratio (MRQ) 0.98
Total Debt/Equity (MRQ) 1.22

Short Interest

as of 4:10 PM ET 10/19/2021
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date 09/30/2021 09/15/2021
Short Interest Shares 2,958 5,394
Short Interest Ratio 0.4 0.5
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:10 ET PM 10/18/2021
Current Qtr
(12/1969)
Next Qtr
(12/1969)
Consensus Estimate n/a n/a
# of Estimates n/a n/a
High Estimate n/a n/a
Low Estimate n/a n/a
Year Ago EPS n/a n/a
Year Over Year Growth Estimate n/a n/a
Current Yr
(12/1969)
Next Yr
(12/1969)
Consensus Estimate n/a n/a
# of Estimates n/a n/a
High Estimate n/a n/a
Low Estimate n/a n/a
Year Ago EPS n/a n/a
Year Over Year Growth Estimate n/a n/a
Current Qtr
(12/1969)
Next Qtr
(12/1969)
Current Year
(12/1969)
Next Year
(12/1969)
Consensus Estimate n/a n/a n/a n/a
# of Estimates n/a n/a n/a n/a
High Estimate n/a n/a n/a n/a
Low Estimate n/a n/a n/a n/a
Year Ago EPS n/a n/a n/a n/a
Year Over Year Growth Estimate n/a n/a n/a n/a

Insider Information Summary

as of n/a
% Insiders - n/a
% Remaining Total Shares - n/a
Current 1 Month
Net Insider Transaction 0.00 0.00
Shares Bought 0.00 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Novavax Lead

Premarket Movers Wednesday - Novavax, Biogen, Netflix

Stocks moving in premarket trading include Netflix, Verizon, Novavax, Biogen and United Airlines.

Biogen Lead

Biogen Beats on Third Quarter Earnings and Raises Guidance

Biogen posts third-quarter earnings that beat forecasts and also ups its full-year profit forecast amid strong expected demand for its Alzheimer's treatment drug.

New York Stock Exchange Lead

Stock Market Today: Dow Slips Lower On Inflation Concern; Tesla Earnings in Focus

Simmering inflation concerns are holding back bulls Wednesday amid a solid earnings season that has the S&P 500 within touching distance of its early September peak.

Verizon a Tremendous Value Despite Earnings Miss, Says GoodHaven Manager

Verizon Posts Earnings Beat and Lifts Guidance on Strong 5G Demand

Verizon posts stronger-than-expected third-quarter earnings and lifts its full-year forecast amid strong consumer demand for 5G-enabled devices and services.

Novavax Lead

Novavax Stock Plunges On Report of COVID Vaccine Production Delays

Politico reported Wednesday that Novavax is facing vaccine production delays linked to concerns over testing standards.

Ford Logo Lead Graphic

Ford Stock Jumps On Credit Suisse Upgrade, Price Target Boost Ahead of Q3 Earnings

Credit Suisse analyst Dan Levy sees both Ford and GM beating Q3 earnings forecasts and boosting near-term profit guidance as the industry works its way out of the global semiconductor shortage.

ProShares Bitcoin Strategy Lead

Bitcoin Skirts Past $64,000 as ProShares ETF Hauls in $570 Million

Bitcoin touches $64,000 for the first time since mid-April as the first bitcoin futures-based U.S. exchange traded fund hauls in more than $570 million in its first day.

Netflix Lead

Netflix Stock Slides After Q3 Earnings Beat; Squid Game Success Powers Subscriber Growth

Squid Game's astonishing success helped lift Asia-Pacific subscriber growth for Netflix and power a solid earnings beat for the streaming service benchmark.

Trump Is Becoming 'an Albatross' Around Wall Street's Neck, Cramer Says

Stocks Cautiously Higher, Netflix Gets 'Squid Game' Boost, Facebook Mulls Rebrand - 5 Things You Must Know

Stocks cautiously higher amid earnings binge; Netflix rides Squid Game to earnings beat; Facebook reportedly planning corporate rebrand; Tesla Q3 earnings in focus and Europe's most vocal inflation hawk calls its quits.

Inflation Lead

Inflation Pressures Coming From All Quarters

AAP team says it’s not a question of rising prices as much as whether companies can pass them along